U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07144345) titled 'Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp' on Aug. 20.
Brief Summary: This Phase 3, randomized, multi-center, evaluator-blind, vehicle-controlled study evaluates the efficacy and safety of reformulated Levulan Kerastick (aminolevulinic acid HCl 20%) combined with photodynamic therapy (PDT) for field-directed treatment of actinic keratosis (AK) on the face or bald scalp. Approximately 160 adult patients with 4-8 mild to moderate AK lesions will be randomized into four treatment arms based on two variables: type of treatment (active drug or vehicle) and incubation time. During the study, ...